$0.1816
-0.0064-3.4%
Last update: Nov 9, 4:00 PM
TScan Therapeutics Inc
TCRXNASDAQ
The average analyst price target for TScan Therapeutics is $6.67, 3572.9% above the current price. Of 6 analysts, 2 rate it Buy and 4 Hold. Targets range from $1 to $15. The latest change came on Sep 8, 2026, when HC Wainwright & Co. downgraded TScan Therapeutics from Buy to Neutral and moved its price target from $7 to $1.
Price Target Range — 10 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
